The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $102.65

Today's change+0.93 +0.91%
Updated January 19 4:15 PM EST. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $102.65

Today's change+0.93 +0.91%
Updated January 19 4:15 PM EST. Delayed by at least 15 minutes.

Celgene Corp up (U.S.)$0.93

Celgene Corp closed up Friday by (U.S.)$0.93 or 0.91% to (U.S.)$102.65. Over the last five days, shares have lost 3.16% and 9.65% over the last 52 weeks. This security has underperformed the S&P 500 by 33.80% during the last year.

Key company metrics

  • Open(U.S.) $102.00
  • Previous close(U.S.) $101.72
  • High(U.S.) $103.05
  • Low(U.S.) $102.00
  • Bid / Ask(U.S.) $102.85 / (U.S.) $103.30
  • YTD % change-1.64%
  • Volume8,112,136
  • Average volume (10-day)8,656,795
  • Average volume (1-month)6,657,412
  • Average volume (3-month)7,145,720
  • 52-week range(U.S.) $94.55 to (U.S.) $147.17
  • Beta1.53
  • Trailing P/E24.18×
  • P/E 1 year forward13.93×
  • Forward PEG0.67×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.24
Updated January 19 4:15 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue3,2873,2682,9602,981
Total other revenue--------
Total revenue3,2873,2682,9602,981
Gross profit3,1693,1572,8472,867
Total cost of revenue118111113114
Total operating expense2,2032,0051,8522,352
Selling / general / administrative608939620685
Research & development1,3478359951,135
Depreciation / amortization808882105
Interest expense (income), net operating--------
Unusual expense (income)503242314
Other operating expenses, total--------
Operating income1,0841,2631,108628
Interest income (expense), net non-operating-136-136-136-136
Gain (loss) on sale of assets--------
Other--------
Income before tax9911,1301,025499
Income after tax9881,061941429
Income tax, total3698470
Net income9881,061941429
Total adjustments to net income--------
Net income before extra. items9881,061941429
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9881,061941429
Inc. avail. to common incl. extra. items9881,061941429
Diluted net income9881,061941429
Dilution adjustment--------
Diluted weighted average shares815812811802
Diluted EPS excluding extraordinary itemsvalue per share1.211.311.160.53
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.271.341.210.87